OPTIMIZATION OF ALEMTUZUMAB DOSE FOR GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS FOR REDUCED INTENSITY TRANSPLANTATION FROM UNRELATED DONORS FOR PATIENTS WITH HEMATOLOGIC MALIGNANCIES

被引：2
|
作者：
Gupta, V [1 ]
Xu, W. [1 ]
Sutherland, R. [2 ]
Kamel-Reid, S. [2 ]
Kuruvilla, J. [1 ]
Loach, D. [1 ]
Lipton, J. H. [1 ]
Messner, H. A. [1 ]
机构：
[1] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
[2] Univ Hlth Network, Toronto, ON, Canada
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2009年 / 15卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2008.12.383
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
348
引用
收藏
页码：124 / 125
页数：2
相关论文
共 50 条
  • [41] Transplantation-associated thrombotic microangiopathy is associated with transplantation from unrelated donors, acute graft-versus-host disease and venoocclusive disease of the liver
    Daly, AS
    Hasegawa, WS
    Lipton, JH
    Messner, HA
    Kiss, TL
    TRANSFUSION AND APHERESIS SCIENCE, 2002, 27 (01) : 3 - 12
  • [42] Sirolimus, tacrolimus, and low-dose methotrexate as graft-versus-host disease prophylaxis in related and unrelated donor reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation
    Alyea, Edwin P.
    Li, Shuli
    Kim, Haesook T.
    Cutler, Corey
    Ho, Vincent
    Soiffer, Robert J.
    Antin, Joseph H.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (08) : 920 - 926
  • [43] THE OUTCOME OF MATCHED UNRELATED DONOR BONE-MARROW TRANSPLANTATION IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES USING MOLECULAR TYPING FOR DONOR SELECTION AND GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS REGIMEN OF CYCLOSPORINE, METHOTREXATE, AND PREDNISONE
    NADEMANEE, A
    SCHMIDT, GM
    PARKER, P
    DAGIS, AC
    STEIN, A
    SNYDER, DS
    ODONNELL, M
    SMITH, EP
    STEPAN, DE
    MOLINA, A
    WONG, KK
    MARGOLIN, K
    SOMLO, G
    LITTRELL, B
    WOO, D
    SNIECINSKI, I
    NILAND, JC
    FORMAN, SJ
    BLOOD, 1995, 86 (03) : 1228 - 1234
  • [44] Unrelated stem cell transplantation after a reduced intensity conditioning regimen containing high-dose thymoglobulin leads to controllable graft-versus-host disease
    Lacerda, J. F.
    Martins, C.
    Lourenco, F.
    Carmo, J. A.
    Juncal, C.
    Oliveira, J. J. G.
    Lacerda, J. M. F.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (04) : 494 - 497
  • [45] Mycophenolate mofetil and cyclosporine for graft-versus-host disease prophylaxis following reduced intensity conditioning allogeneic stem cell transplantation
    Mohty, M
    de Lavallade, H
    Faucher, C
    Bilger, K
    Vey, N
    Stoppa, AM
    Gravis, G
    Coso, D
    Viens, P
    Gastaut, JA
    Blaise, D
    BONE MARROW TRANSPLANTATION, 2004, 34 (06) : 527 - 530
  • [46] Mycophenolate mofetil and cyclosporine for graft-versus-host disease prophylaxis following reduced intensity conditioning allogeneic stem cell transplantation
    M Mohty
    H de Lavallade
    C Faucher
    K Bilger
    N Vey
    A-M Stoppa
    G Gravis
    D Coso
    P Viens
    J-A Gastaut
    D Blaise
    Bone Marrow Transplantation, 2004, 34 : 527 - 530
  • [47] Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host disease prophylaxis in mismatched related donor or unrelated donor transplantation
    Antin, JH
    Kim, HT
    Cutler, C
    Ho, VT
    Lee, SJ
    Miklos, DB
    Hochberg, EP
    Wu, CJ
    Alyea, EP
    Soiffer, RJ
    BLOOD, 2003, 102 (05) : 1601 - 1605
  • [48] Low-dose antithymocyte globulin inhibits chronic graft-versus-host disease in peripheral blood stem cell transplantation from unrelated donors
    Shiratori, Souichi
    Sugita, Junichi
    Fuji, Shigeo
    Aoki, Jun
    Sawa, Masashi
    Ozawa, Yukiyasu
    Hashimoto, Daigo
    Matsuoka, Ken-ichi
    Imada, Kazunori
    Doki, Noriko
    Ashida, Takashi
    Ueda, Yasunori
    Tanaka, Masatsugu
    Sawayama, Yasushi
    Ichinohe, Tatsuo
    Terakura, Seitaro
    Morishima, Satoko
    Atsuta, Yoshiko
    Fukuda, Takahiro
    Teshima, Takanori
    BONE MARROW TRANSPLANTATION, 2021, 56 (09) : 2231 - 2240
  • [49] Low-dose antithymocyte globulin inhibits chronic graft-versus-host disease in peripheral blood stem cell transplantation from unrelated donors
    Souichi Shiratori
    Junichi Sugita
    Shigeo Fuji
    Jun Aoki
    Masashi Sawa
    Yukiyasu Ozawa
    Daigo Hashimoto
    Ken-ichi Matsuoka
    Kazunori Imada
    Noriko Doki
    Takashi Ashida
    Yasunori Ueda
    Masatsugu Tanaka
    Yasushi Sawayama
    Tatsuo Ichinohe
    Seitaro Terakura
    Satoko Morishima
    Yoshiko Atsuta
    Takahiro Fukuda
    Takanori Teshima
    Bone Marrow Transplantation, 2021, 56 : 2231 - 2240
  • [50] LOW DOSE ALEMTUZUMAB FOR GRAFT VERSUS HOST DISEASE PROPHYLAXIS IN MATCHED SIBLING DONOR HEMATOPOIETIC CELL TRANSPLANTATION
    Liga, Maria
    Tsokanas, Dimitrios
    Sagiadinou, Elefteria
    Triantafyllou, Evangelia
    Valera, Krisela
    Christopoulou, Anastasia
    Zacharioudaki, Vassiliki
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 367 - 368
12345